Filing Details

Accession Number:
0001415889-23-004107
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-03 16:18:29
Reporting Period:
2023-03-01
Accepted Time:
2023-03-03 16:18:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726221 Andrew Turitz C/O Teladoc Health, Inc.
2 Manhattanville Road, Suite 203
Purchase NY 10577
Svp - Corporate Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-01 5,389 $0.00 20,183 No 4 M Direct
Common Stock Disposition 2023-03-02 1,801 $25.36 18,382 No 4 S Direct
Common Stock Acquisiton 2023-03-02 1,205 $0.00 19,587 No 4 M Direct
Common Stock Acquisiton 2023-03-02 2,048 $0.00 21,635 No 4 M Direct
Common Stock Acquisiton 2023-03-02 515 $0.00 22,150 No 4 M Direct
Common Stock Acquisiton 2023-03-02 1,147 $0.00 23,297 No 4 M Direct
Common Stock Acquisiton 2023-03-02 867 $0.00 24,164 No 4 M Direct
Common Stock Acquisiton 2023-03-02 437 $0.00 24,601 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-03-01 5,389 $0.00 5,389 $0.00
Common Stock Restricted Stock Units Disposition 2023-03-02 1,205 $0.00 1,205 $0.00
Common Stock Performance Stock Units Disposition 2023-03-02 2,048 $0.00 2,048 $0.00
Common Stock Performance Stock Units Disposition 2023-03-02 515 $0.00 515 $0.00
Common Stock Restricted Stock Units Disposition 2023-03-02 1,147 $0.00 1,147 $0.00
Common Stock Performance Stock Units Disposition 2023-03-02 867 $0.00 867 $0.00
Common Stock Performance Stock Units Acquisiton 2023-03-02 874 $0.00 874 $0.00
Common Stock Performance Stock Units Disposition 2023-03-02 437 $0.00 437 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,781 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
1,148 No 4 M Direct
867 No 4 M Direct
874 No 4 A Direct
437 No 4 M Direct
Footnotes
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. Performance stock units convert to shares of TDOC common stock on a one-for-one basis
  4. On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  5. On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  6. On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
  7. On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
  8. On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  9. On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
  10. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  11. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.
  12. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.
  13. On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.